News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Accelrys Inc. (ACCL) Bags Irish Software Developer QUMAS for $50 Million



12/11/2013 6:54:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

San Diego scientific software developer Accelrys (NASDAQ: ACCL) says it has paid about $50 million in cash to acquire Qumas, an Irish specialist in compliance and quality management software.

The aquisition marks the fifth deal for Accelrys over the past two years, beginning with its $35 million buyout of Hopkinton, MA-based VelQuest and $30 million acquisition of Lafayette, CO-based Aegis Analytical Corp. in 2012. Accelrys bought the Swiss biosciences software company Vialis for $5 million and Fairfield, CA-based ChemSW for $15.3 million earlier this year.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy
Read at Street Insider
Read at Irish Independent
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES